Did you know that heparin, one of the most commonly used anticoagulants in hospitals, can, in some cases, trigger a serious, life-threatening immune reaction in certain patients?
Yes, this complication is known as heparin-induced thrombocytopenia (HIT), and it occurs when antibodies to heparin activate platelets, leading to clots throughout the circulatory system, dramatically lowering platelet counts, and increasing the risk of bleeding. Complications of HIT include deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction, amputation, and death, with mortality rates for HIT exceeding 20% in some studies. In the United States, an estimated 10,000 cases of Heparin-induced thrombocytopenia occur each year.
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.